WebMar 11, 2012 · Hospira, a provider of injectable drugs and infusion technologies, has gained regulatory clearance from the US Food and Drug Administration (FDA) for its Symbiq 3.13 infusion device, the improved version of the company’s infusion system platform. The Symbiq infusion system is a device designed to help improve workflow and decrease … WebMar 8, 2012 · The Symbiq device's FDA clearance is not expected to impact Hospira's 2012 financial projections, which were issued on Feb. 14, 2012. About Hospira Hospira, Inc. is the world's leading provider of ...
Hospira Receives FDA Clearance for Symbiq™ 3.13 Infusion Pump
WebJul 31, 2015 · Hospira said it plans to phase out the Symbiq system in May, after the FDA warned on cybersecurity vulnerability issues with its remotely-programmed LifeCare PCA3 and PCA5 devices. “As... WebJul 31, 2015 · Hospira said it plans to phase out the Symbiq system in May, after the FDA warned on cybersecurity vulnerability issues with its remotely-programmed LifeCare PCA3 … bakshi aleksandre
Hospira Gets Warning Letter After FDA Inspection
WebJul 31, 2015 · 31 July 2015, 5:50 pm By Jim Finkle BOSTON (Reuters) - The U.S. Food and Drug Administration on Friday advised hospitals not to use Hospira Inc's Symbiq infusion system, saying a security... WebDevice Recall LifeShield Symbiq Pump Set Model / Serial Lot number: 702185H Product Classification ... Latex-Free, non-DEHP, 20 drops/mL; a sterile Rx single use device; Hospira Inc, Lake Forest, IL USA, Hospira, Finisklin Business Park, Sligo, Ireland, Made in Costa Rica; product 160490728, REF 16049 . Manufacturer Hospira Inc. 1 Event WebOct 31, 2012 · The Hospira Symbiq Infusion System recall was posted by the FDA on October 29, indicating that the device may deliver the wrong amount of medication or … bakshi anand